Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06904365 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Study acronym: OvAR-Y
StatusRecruiting
PhaseNot specified
Started2025-04-08
View on ClinicalTrials.gov ↗
Female patients with early onset (\<50 years old) pelvic malignancies such as uterine and rectal cancers are rising in incidence, which often requires pelvic radiation; many of these patients are premenopausal and at a high risk of premature ovarian failure from radiotherapy. Premature ovarian failure carries significant cardiac, musculoskeletal, sexual, and psychosocial morbidity. Ovarian transposition carries variable success rates, is not readily accessible to the general population, and can still be at risk of clinically significant radiotherapy doses. There is an unmet need for innovative techniques to protect ovarian function.

Amendment history 9 changes detected by DataLookout

2026-09-03
notable
Sponsor refiled this as recruiting (was completed)
2026-08-25
notable
Trial completed
2026-07-19
notable
Primary completion pushed: 2026-07-10 → 2026-08-31
2026-07-19
minor
Completion pushed: 2026-07-10 → 2026-08-31
2026-07-02
notable
Primary completion pushed: 2026-05-31 → 2026-07-10
2026-07-02
minor
Completion pushed: 2026-05-31 → 2026-07-10
2026-05-19
notable
Trial status changed: Recruiting → Active, Not Recruiting
2026-05-19
minor
Primary completion moved earlier: 2026-06-30 → 2026-05-31
2026-05-19
minor
Completion moved earlier: 2026-06-30 → 2026-05-31
Trial Details
NCT Number NCT06904365
Lead Sponsor Washington University School of Medicine
Collaborators: Varian Medical Systems
Conditions Uterine Cancer, Rectal Cancer, Colon Cancer, Breast Cancer, Lung Cancer, Sarcoma, Cervix Cancer, Head and Neck Cancer +4 more
Enrollment 11 participants
Start Date 2025-04-08
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-02